...
首页> 外文期刊>Journal of Organometallic Chemistry >Di- and tri-organotin(IV) complexes with 2-hydroxy-1-naphthaldehyde 5-chloro-2-hydroxybenzoylhydrazone: Synthesis, characterization and in vitro antitumor activities
【24h】

Di- and tri-organotin(IV) complexes with 2-hydroxy-1-naphthaldehyde 5-chloro-2-hydroxybenzoylhydrazone: Synthesis, characterization and in vitro antitumor activities

机译:二和三有机锡(IV)与2-羟基-1-萘甲醛5-氯-2-羟基苯甲酰hydr的配合物:合成,表征和体外抗肿瘤活性

获取原文
获取原文并翻译 | 示例
           

摘要

Series of new organotin(IV) complexes of the types R2SnL, R is Me (1), Ph (2), o-Cl-C_6H_4CH_2 (3); and [R _3SnL]_∞, R = n-Bu (4) (H_2L = 2-hydroxy-1-naphthaldehyde 5-chloro-2-hydroxybenzoylhydrazone) have been synthesized and structurally characterized by means of elemental analysis, FT-IR, UV-vis spectroscopy, NMR (~1H, ~(13)C and ~(119)Sn) spectra and X-ray single crystal diffraction analyses. Structural analyses reveal that complexes 1-3 show similar monomeric structure, in which the tin center is coordinated with the enolic tridentate ligand (L) in the ONO chelate mode and exhibits five-coordinated trigonal bipyramidal geometry. Unexpectedly, complex 4 presents as a rare one-dimensional chain polymeric structure, in which the coordination of Sn is also five-coordinated trigonal bipyramidal geometry and the segment of tri-n-butyltin is bridged by the de-protonated phenolate O atom and the carbonyl O atom from the non-enolic Schiff base ligand. All compounds exhibit good in vitro antitumor activity toward human colon cancer cells (HCT-8), lung cancer cells (A549) and human promyelocyticfina leukemic cells (HL-60). The results indicate that both alkyl groups bound with tin centers and the structural of organotin compounds have significant effect on their in vitro antitumor activities. Among them, the polymeric tri-n-butyltin Schiff base complex 4 is the most active one, and the complex 3 shows high selectivity on the tumor cells HCT-8 and HL-60. For all of the title compounds, there was a good dose-effect relationship.
机译:R2SnL类型的一系列新的有机锡(IV)配合物,R为Me(1),Ph(2),o-Cl-C_6H_4CH_2(3);和[R _3SnL]_∞,R = n-Bu(4)(H_2L = 2-羟基-1-萘醛5-氯-2-羟基苯甲酰hydr)并通过元素分析,FT-IR,紫外可见光谱,NMR(〜1H,〜(13)C和〜(119)Sn)光谱和X射线单晶衍射分析。结构分析表明,配合物1-3表现出相似的单体结构,其中锡中心与ONO螯合模式下的烯丙基三齿配体(L)配位,并呈现出五配位的三角双锥体几何形状。出乎意料的是,配合物4呈现为罕见的一维链状聚合物结构,其中Sn的配位也是五配位的三角双锥体几何形状,三正丁基锡的片段被去质子化的酚盐O原子和来自非烯丙基席夫碱配体的羰基O原子。所有化合物均对人结肠癌细胞(HCT-8),肺癌细胞(A549)和人早幼粒细胞白血病细胞(HL-60)表现出良好的体外抗肿瘤活性。结果表明,与锡中心键合的烷基和有机锡化合物的结构均对其体外抗肿瘤活性具有重要影响。其中,聚合的三正丁基锡席夫碱复合物4是活性最高的,并且复合物3对肿瘤细胞HCT-8和HL-60具有高选择性。对于所有标题化合物,都存在良好的剂量效应关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号